Mega Genomics Stock

Mega Genomics EBITDA per Share

The EBITDA per Share of Mega Genomics (6667.HK) as of Aug 9, 2026 is 0.20 CNY. In the previous year, EBITDA per Share was 0.32 CNY — a change of -36.70% (lower).

EBITDA per Share

0.20CNY

YoY

-36.70%

Last updated:

EBITDA per Share of Mega Genomics is 2026 0.20 CNY. EBITDA per Share of Mega Genomics was 2025 0.32 CNY. It decreases by -36.70% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Mega Genomics Stock analysis

What does Mega Genomics do? Mega Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mega Genomics stock

EBITDA per Share of Mega Genomics is 0.20 CNY in 2026.

EBITDA per Share of Mega Genomics changed from 0.32 CNY to 0.20 CNY, representing a -36.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Mega Genomics since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Mega Genomics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Mega Genomics